造血幹細胞由来線維芽細胞および筋線維芽細胞の同定とその臨床応用

書誌事項

タイトル別名
  • Identification and Clinical Application of Fibroblasts/Myofibroblasts Derived from Hematopoietic Stem Cells

この論文をさがす

抄録

Tissue fibrobiasts/myofibroblasts play a key role in growth factor secretion and extracellularmatrix protein production, and therefore regulate the inflammation responses in the processes of wound healing. Once the origin of tissue fibroblasts/myofibroblasts was thought to be local tissues themselves; recently, it was proved that the fibroblasts/myofibroblasts are derived from bone marrow. We have carried out studies of tissue reconstitution by transplanting clones derived from a single hematopoietic stem cell (HSC) expressing transgenic enhanced green fluorescent protein (EGFP). We found that there were EGFP+ fibroblasts/myofibroblasts in many organs and tissues which were derived from the HSC, excluding the possibility of cell fusion. Since fibroblasts/myofibroblasts are important in the pathological process and maintenance of steady state, it is of interest for the application of regenerative medicine to clarify the newly identified road from HSC to fibroblasts/myofibroblasts

収録刊行物

参考文献 (37)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ